MyFinsight
Home
Blog
About
Accounts receivable, net
$285,102K
(33.84%↑ Y/Y)
Cash and cash
equivalents
$129,467K
(10.33%↑ Y/Y)
Inventory
$113,269K
(196.92%↑ Y/Y)
Prepaid expenses and
other current assets
$60,326K
(7.65%↑ Y/Y)
Restricted cash
$19,850K
(0.00%↑ Y/Y)
Intangible assets, net
$1,186,084K
(51.97%↑ Y/Y)
Total current assets
$608,014K
(10.71%↑ Y/Y)
Goodwill
$190,177K
(28.55%↑ Y/Y)
Deferred tax assets
$120,774K
(31.32%↑ Y/Y)
Other noncurrent
assets
$15,237K
(296.28%↑ Y/Y)
Property and equipment,
net
$10,653K
(-17.44%↓ Y/Y)
Operating lease assets
$3,791K
(-27.97%↓ Y/Y)
Restricted cash
$1,060K
(0.95%↑ Y/Y)
Total assets
$2,135,790K
(34.10%↑ Y/Y)
Total liabilities and
shareholders equity
$2,135,790K
(34.10%↑ Y/Y)
Total liabilities
$1,823,881K
(34.07%↑ Y/Y)
Total shareholders
equity
$311,909K
(34.32%↑ Y/Y)
Treasury stock, at cost
9,028,722 shares as of...
$222,510K
(2.30%↑ Y/Y)
Accumulated deficit
-$101,684K
(32.03%↑ Y/Y)
Term notes payable,
net of current...
$797,824K
(53.24%↑ Y/Y)
Total current
liabilities
$589,861K
(26.96%↑ Y/Y)
Convertible senior notes
$238,733K
(0.44%↑ Y/Y)
Deferred royalty
obligation
$121,357K
(-1.04%↓ Y/Y)
Deferred tax liabilities
$40,965K
Contingent consideration,
net of current...
$22,956K
Deferred revenue, net of
current portion
$8,778K
(-12.22%↓ Y/Y)
Operating lease
liabilities, net of current...
$3,407K
(-29.80%↓ Y/Y)
Additional paid-in capital
$636,062K
(6.20%↑ Y/Y)
Common stock, 0.001 par
value authorized...
$41K
(2.50%↑ Y/Y)
Accrued rebates,
returns and discounts
$406,854K
(30.92%↑ Y/Y)
Accrued liabilities
$71,250K
(19.88%↑ Y/Y)
Current portion of term
notes payable
$55,000K
(-14.84%↓ Y/Y)
Business combination
consideration payable
$29,719K
(69.18%↑ Y/Y)
Current portion of
contingent consideration
$15,569K
(40871.05%↑ Y/Y)
Accounts payable
$9,241K
(-15.14%↓ Y/Y)
Current portion of
operating lease...
$1,561K
(16.67%↑ Y/Y)
Deferred revenue
$667K
(-93.33%↓ Y/Y)
Back
Back
Balance Sheet
COLLEGIUM PHARMACEUTICAL, INC (COLL)
COLLEGIUM PHARMACEUTICAL, INC (COLL)
source: myfinsight.com